全文获取类型
收费全文 | 3028篇 |
免费 | 370篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 110篇 |
妇产科学 | 41篇 |
基础医学 | 275篇 |
口腔科学 | 144篇 |
临床医学 | 403篇 |
内科学 | 627篇 |
皮肤病学 | 47篇 |
神经病学 | 205篇 |
特种医学 | 373篇 |
外科学 | 245篇 |
综合类 | 47篇 |
一般理论 | 1篇 |
预防医学 | 509篇 |
眼科学 | 17篇 |
药学 | 161篇 |
肿瘤学 | 187篇 |
出版年
2023年 | 49篇 |
2022年 | 18篇 |
2021年 | 26篇 |
2020年 | 49篇 |
2019年 | 33篇 |
2018年 | 64篇 |
2017年 | 50篇 |
2016年 | 61篇 |
2015年 | 70篇 |
2014年 | 121篇 |
2013年 | 163篇 |
2012年 | 122篇 |
2011年 | 148篇 |
2010年 | 113篇 |
2009年 | 109篇 |
2008年 | 106篇 |
2007年 | 119篇 |
2006年 | 112篇 |
2005年 | 85篇 |
2004年 | 94篇 |
2003年 | 58篇 |
2002年 | 48篇 |
2001年 | 79篇 |
2000年 | 66篇 |
1999年 | 69篇 |
1998年 | 78篇 |
1997年 | 104篇 |
1996年 | 92篇 |
1995年 | 69篇 |
1994年 | 74篇 |
1993年 | 63篇 |
1992年 | 62篇 |
1991年 | 48篇 |
1990年 | 66篇 |
1989年 | 77篇 |
1988年 | 73篇 |
1987年 | 66篇 |
1986年 | 66篇 |
1985年 | 70篇 |
1984年 | 34篇 |
1983年 | 31篇 |
1982年 | 34篇 |
1981年 | 46篇 |
1980年 | 26篇 |
1979年 | 28篇 |
1977年 | 22篇 |
1976年 | 28篇 |
1975年 | 18篇 |
1974年 | 18篇 |
1972年 | 15篇 |
排序方式: 共有3422条查询结果,搜索用时 15 毫秒
61.
Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon. 总被引:15,自引:3,他引:15 下载免费PDF全文
T W Chang S McKinney V Liu P C Kung J Vilcek J Le 《Proceedings of the National Academy of Sciences of the United States of America》1984,81(16):5219-5222
Mouse monoclonal antibodies B1 and B3 are specific for natural and Escherichia coli-derived recombinant human gamma-interferon (IFN-gamma). The two antibodies recognize different epitopes of the IFN-gamma molecule and do not compete with each other's binding. We have used these two antibodies to construct a solid-phase, sandwich immunoradiometric assay for human IFN-gamma. Purified antibody B1 was coated on polystyrene beads (0.64 cm in diameter) and used as the solid-phase immunoadsorbent and antibody B3 was labeled with 125I and used as tracer. This assay can be completed in about 4 hr and is capable of detecting IFN-gamma levels in human serum or tissue culture fluids as low as 0.1 NIH reference unit/ml. Recombinant human IFN-gamma derived from E. coli was detectable at a concentration of 0.02 ng/ml. The assay appears to be specific for the biologically active forms of IFN-gamma, since after exposure to pH 2, 37 degrees C, or 56 degrees C, biological activity and reactivity in the immunoradiometric assay decreased in parallel. The immunoradiometric assay can be employed for the analysis of the structural characteristics of the human IFN-gamma molecule. 相似文献
62.
Brandon P. Verdoorn MD Tamara K. Evans BS Gregory J. Hanson MD Yi Zhu PhD Larissa G. P. Langhi Prata PhD Robert J. Pignolo MD PhD Elizabeth J. Atkinson MS Erin O. Wissler-Gerdes MA George A. Kuchel MD Joan B. Mannick MD Stephen B. Kritchevsky PhD Sundeep Khosla MD Stacey A. Rizza MD Jeremy D. Walston MD Nicolas Musi MD Lewis A. Lipsitz MD Douglas P. Kiel MD Raymond Yung MB ChB Nathan K. LeBrasseur PhD Ravinder J. Singh PhD Teresa McCarthy MD MS Michael A. Puskarich MD Laura J. Niedernhofer MD PhD Paul D. Robbins PhD Matthew Sorenson JD MA Tamara Tchkonia PhD James L. Kirkland MD PhD 《Journal of the American Geriatrics Society》2021,69(11):3023-3033
The burden of senescent cells (SnCs), which do not divide but are metabolically active and resistant to death by apoptosis, is increased in older adults and those with chronic diseases. These individuals are also at the greatest risk for morbidity and mortality from SARS-CoV-2 infection. SARS-CoV-2 complications include cytokine storm and multiorgan failure mediated by the same factors as often produced by SnCs through their senescence-associated secretory phenotype (SASP). The SASP can be amplified by infection-related pathogen-associated molecular profile factors. Senolytic agents, such as Fisetin, selectively eliminate SnCs and delay, prevent, or alleviate multiple disorders in aged experimental animals and animal models of human chronic diseases, including obesity, diabetes, and respiratory diseases. Senolytics are now in clinical trials for multiple conditions linked to SnCs, including frailty; obesity/diabetes; osteoporosis; and cardiovascular, kidney, and lung diseases, which are also risk factors for SARS-CoV-2 morbidity and mortality. A clinical trial is underway to test if senolytics decrease SARS-CoV-2 progression and morbidity in hospitalized older adults. We describe here a National Institutes of Health-funded, multicenter, placebo-controlled clinical trial of Fisetin for older adult skilled nursing facility (SNF) residents who have been, or become, SARS-CoV-2 rtPCR-positive, including the rationale for targeting fundamental aging mechanisms in such patients. We consider logistic challenges of conducting trials in long-term care settings in the SARS-CoV-2 era, including restricted access, consent procedures, methods for obtaining biospecimens and clinical data, staffing, investigational product administration issues, and potential solutions for these challenges. We propose developing a national network of SNFs engaged in interventional clinical trials. 相似文献
63.
Kahli Zietlow MD Leslie Dubin MSW Alethia Battles JD MSW Caroline Vitale MD 《Journal of the American Geriatrics Society》2022,70(11):3070-3079
Guardianship may pose an ethical dilemma for physicians, who must balance protecting vulnerable patients from potential safety concerns with respecting their autonomy. Older adults with dementia are particularly susceptible to loss of independence and the ability to participate in medical decision making. To have the capacity for medical decision making, individuals must understand relevant information, appreciate their circumstances, demonstrate reasoning, and express a consistent choice free from coercion. Although capacity assessments are usually task-specific, geriatricians and other specialists may be asked to comment on capacity more globally. These determinations may be used to support a Petition for the Appointment of a Guardian of a Legally Incapacitated Adult, the legal process of pursuing guardianship in probate court. Assigned guardians may be known to the incapacitated individual (e.g., a family member or friend) or may be professional guardians with no prior relationship to the ward. Guardians are encouraged to use substituted decision-making, taking into account the ward's previously expressed values and preferences. Although a number of viable alternatives to guardianship exist, numerous systemic barriers may prevent these from being fully explored. The ongoing need for guardianship should be periodically revisited and reassessed. Data about guardians and wards is shockingly sparse, as there are no centralized databases. Laws and regulations for guardianships vary significantly between states. Physicians can serve as important allies and advocates for patients with cognitive impairment at risk of incapacity, can help preserve their autonomy for as long as possible, and ensure appropriate protections are in place if the patient does lose their decision-making ability. 相似文献
64.
Reed JL Brewah YA Delaney T Welliver T Burwell T Benjamin E Kuta E Kozhich A McKinney L Suzich J Kiener PA Avendano L Velozo L Humbles A Welliver RC Coyle AJ 《The Journal of infectious diseases》2008,198(12):1783-1793
Although respiratory syncytial virus (RSV) infection is the most important cause of bronchiolitis in infants, the pathogenesis of RSV disease is poorly described. We studied histopathologic changes in a panel of lung tissue specimens obtained from infants with fatal cases of primary RSV infection. In these tissues, airway occlusion with accumulations of infected, apoptotic cellular debris and serum protein was consistently observed. Similar observations were found after RSV infection in New Zealand black (NZB) mice, which have constitutive deficiencies in macrophage function, but not in BALB/c mice. A deficiency in the number of alveolar macrophages in NZB mice appears to be central to enhanced disease, because depletion of alveolar macrophages in BALB/c mice before RSV exposure resulted in airway occlusion. In mice with insufficient numbers of macrophages, RSV infection yielded an increased viral load and enhanced expression of type I interferon-associated genes at the height of disease. Together, our data suggest that innate, rather than adaptive, immune responses are critical determinants of the severity of RSV bronchiolitis. 相似文献
65.
Gamma-aminobutyric acid type A receptors modulate cAMP-mediated long-term potentiation and long-term depression at monosynaptic CA3-CA1 synapses 总被引:2,自引:0,他引:2 下载免费PDF全文
Yu TP McKinney S Lester HA Davidson N 《Proceedings of the National Academy of Sciences of the United States of America》2001,98(9):5264-5269
cAMP induces a protein-synthesis-dependent late phase of long-term potentiation (LTP) at CA3-CA1 synapses in acute hippocampal slices. Herein we report cAMP-mediated LTP and long-term depression (LTD) at monosynaptic CA3-CA1 cell pairs in organotypic hippocampal slice cultures. After bath application of the membrane-permeable cAMP analog adenosine 3',5'-cyclic monophosphorothioate, Sp isomer (Sp-cAMPS), synaptic transmission was enhanced for at least 2 h. Consistent with previous findings, the late phase of LTP requires activation of cAMP-dependent protein kinase A and protein synthesis. There is also an early phase of LTP induced by cAMP; the early phase depends on protein kinase A but, in contrast to the later phase, does not require protein synthesis. In addition, the cAMP-induced LTP is associated with a reduction of paired-pulse facilitation, suggesting that presynaptic modification may be involved. Furthermore, we found that Sp-cAMPS induced LTD in slices pretreated with picrotoxin, a gamma-aminobutyric acid type A (GABA(A)) receptor antagonist. This form of LTD depends on protein synthesis and protein phosphatase(s) and is accompanied by an increased ratio of failed synaptic transmission. These results suggest that GABA(A) receptors can modulate the effect of cAMP on synaptic transmission and thus determine the direction of synaptic plasticity. 相似文献
66.
67.
68.
69.
70.